Home

Disgrace Mittens Panorama remap cap tumor Panther nothing

Low-cost dexamethasone reduces death by up to one third in hospitalised  patients with severe respiratory complications of COVID-19 — REMAP-CAP Trial
Low-cost dexamethasone reduces death by up to one third in hospitalised patients with severe respiratory complications of COVID-19 — REMAP-CAP Trial

remap-cap (@remap_cap) / X
remap-cap (@remap_cap) / X

Understanding Adaptive Platform Trials & REMAP-CAP - SingHealth
Understanding Adaptive Platform Trials & REMAP-CAP - SingHealth

NHMRC Clinical Trial Centre | Improving Health Outcomes
NHMRC Clinical Trial Centre | Improving Health Outcomes

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial

REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 |  Imperial News | Imperial College London
REMAP-CAP awarded Critical Care Team of the Year at The BMJ Awards 2021 | Imperial News | Imperial College London

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line

remap-cap (@remap_cap) / X
remap-cap (@remap_cap) / X

REMAP-CAP Trial
REMAP-CAP Trial

Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients |  Imperial News | Imperial College London
Statement from the REMAP-CAP trial on blood thinners in COVID-19 patients | Imperial News | Imperial College London

Homepage - REMAPCAP
Homepage - REMAPCAP

How will 'mega-trials' identify the most effective treatments for COVID-19,  and when will they report? - Coronavirus: the science explained - UKRI
How will 'mega-trials' identify the most effective treatments for COVID-19, and when will they report? - Coronavirus: the science explained - UKRI

May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive  Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials
May 15, 2020: Optimized Learning While Doing: The REMAP-CAP Adaptive Platform Trial (Derek Angus, MD, MPH) - Rethinking Clinical Trials

Homepage - REMAPCAP
Homepage - REMAPCAP

Full article: Efficient Adaptive Designs for Clinical Trials of  Interventions for COVID-19
Full article: Efficient Adaptive Designs for Clinical Trials of Interventions for COVID-19

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial

Innovation, collaboration and patient-focused research | UCD Covid-19  Response
Innovation, collaboration and patient-focused research | UCD Covid-19 Response

REMAP-CAP 紹介 – REMAP-CAP Japan
REMAP-CAP 紹介 – REMAP-CAP Japan

Homepage - REMAPCAP
Homepage - REMAPCAP

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial

REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 | tctmd.com
REMAP-CAP: Mixed Results for Antiplatelets in Critical COVID-19 | tctmd.com

REMAP-CAP • Coronavirus
REMAP-CAP • Coronavirus

REMAP-CAP – The Bottom Line
REMAP-CAP – The Bottom Line

Media — REMAP-CAP Trial
Media — REMAP-CAP Trial